Abstract: There is provided soybean protein products of significantly lowerstachyose content as a function of an improved soybean having a seed stachyose content of less than 50 .mu.mol/g. Improved soybean lines are provided as are methods of using such reduced stachyose soybeans.

Abstract: Improved vaccine compositions and methods of making same are provided, which vaccines are characterized by an antigen from a pathogen and an effective adjuvanting amount of Interleukin-12. These IL-12 adjuvanted vaccines are capable of increasing the vaccinated host's cell mediated immune response to provide an increased and protective immune response to the pathogen. Also disclosed are methods for vaccinating hosts by administering a vaccine containing an antigen from a pathogenic microorganism and co-administering an adjuvanting amount of IL-12. Vaccines or therapeutic compositions directed against a cancer may also be adjuvanted with IL-12 according to this invention.

Abstract: A novel soybean cultivar, designated 92160630750456, is disclosed. The invention relates to the seeds of soybean cultivar 92160630750456, to the plants of soybean 92160630750456 and to methods for producing a soybean plant produced by crossing the cultivar 92160630750456 with itself or another soybean variety. The invention further relates to hybrid soybean seeds and plants produced by crossing the cultivar 92160630750456 with another soybean cultivar.

Abstract: This invention relates to a novel isoflavone-enriched soy protein product and a method used for its manufacture. The finished soy protein product displays desirable flavor and functional properties, and its isoflavone content is substantially increased compared to traditional soy protein concentrates and isolates. In addition the total sulfur containing amino acid content is improved compared to soy protein isolates. The method for the manufacture of the novel soy protein product results in improved yield and reduced waste products compared to those used to manufacture soy protein concentrates and isolates. The novel soy protein product displays desirable flavor, composition, and performance as an ingredient in the production of dairy or meat based food products such as infant formula, nutritional beverage, milk replacer, soy extended bologna, imitation processed cheese spread, water-injected ham, yogurt and frozen dessert.

Abstract: A computer system with secured data paths consists of a main computer with a main processor, associated main memory, main input/output devices, and main data paths interconnecting the main processor, main memory, and main input/output devices; a security computer with a security processor, security memory, an operator console, and security data paths, connected to the main data paths of the main computer so as to intercept all data flowing along the main data paths; and a test computer with a test processor, test memory, test input/output devices, and test data paths, connected to the security computer. The main computer executes user programs, the security computer executes security programs, and the test computer test-executes user programs.

Abstract: An apparatus and method for dynamic encryption of information including data, voice, and graphics, consisting of a random access memory containing encryption and decryption programs and the information to be encrypted and decrypted, an encryption processor executing the encryption and decryption programs, the encryption and decryption programs being a code set whose members are distinct encryption/decryption codes executed serially by the encryption processor to encrypt and decrypt the information, and also being optionally repetitively executed, and a data set in the random access memory specifying the order and execution and number of repetitions of each member of the code set.

Abstract: Improved vaccine compositions and methods of making same are provided, which vaccines are characterized by an antigen from a pathogen and an effective adjuvanting amount of Interleukin-12. These IL-12 adjuvanted vaccines are capable of increasing the vaccinated host's cell mediated immune response to provide an increased and protective immune response to the pathogen. Also disclosed are methods for vaccinating hosts by administering a vaccine containing an antigen from a pathogenic microorganism and co-administering an adjuvanting amount of IL-12. Vaccines or therapeutic compositions directed against a cancer may also be adjuvanted with IL-12 according to this invention.

Abstract: There is provided soybean protein products of significantly lowerstachyose content as a function of an improved soybean having a seed stachyose content of less than 50 .mu.mol/g. Improved soybean lines are provided as are methods of using such reduced stachyose soybeans.

Abstract: Improved vaccine compositions and methods of making the compositions are provided, which vaccines are characterized by an antigen from a pathogen and an effective adjuvanting amount of Interleukin-12 (IL-12). These IL-12 adjuvanted vaccines are capable of increasing the vaccinated host's cell mediated immune response to provide an increased and protective immune response to the pathogen. Also disclosed are methods for vaccinating hosts by administering a vaccine containing an antigen from a pathogenic microorganism and co-administering an adjuvanting amount of IL-12. Vaccines or therapeutic compositions directed against a cancer may also be adjuvanted with IL-12 according to this invention.